Evidence map›Paper›PMID 23900520›Full record

Observational studyEuropean journal of pediatrics2013

High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study.

Silvia Bressan, Marco Balzani, Baruch Krauss, Andrea Pettenazzo, Stefania Zanconato, Eugenio Baraldi

3 registry-linked trialsOpen access · bronzeAbstract readObservational Study
In one paragraph

Observational study in European journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02373683 naterminatednot on this mapstarted 2014, after this paper: background citation

Helium-oxygen Gas Mixtures Delivered by a High Flow Nasal Cannula in Bronchiolitis

TypeinterventionalSponsorCase Western Reserve UniversityRan2014 to 2015Enrolled10ConditionsBronchiolitis, Heliox, PediatricsArmsVapotherm-Heliox
NCT03342781 nacompletednot on this mapstarted 2016, after this paper: background citation

Using a High-flow Nasal Cannula Provided Superior Results to Diffuser Delivery in Severe Bronchiolitis: a Prospective, Randomized Controlled Study

TypeinterventionalSponsorKayseri Training and Research HospitalRan2016 to 2017Enrolled60ConditionsRespiratory Failure, BronchiolitisArmshigh flow nasal oxygen therapy, Diffuser oxygen mask
NCT04245202 nacompletednot on this mapstarted 2017, after this paper: background citation

Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Moderate and Severe Bronchiolitis; a Randomized Controlled Trial

TypeinterventionalSponsorEge UniversityRan2017 to 2020Enrolled87ConditionsAcute BronchiolitisArmsHFNCOT, St-FMOT
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Heliox inhalation therapy for bronchiolitis in infants.The Cochrane database of systematic reviews · 2015
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nasal high flow therapy for primary respiratory support in preterm infants.The Cochrane database of systematic reviews · 2023
    Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Silvia BressanDepartment of Women's and Children's Health, University of Padova, Via Giustiniani 3, 35128, Padova, Italy, silviabress@gmail.com.
Marco Balzani
Baruch Krauss
Andrea Pettenazzo
Stefania Zanconato
Eugenio Baraldi
University of Padua · ITHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledHigh-flow nasal cannula (HFNC) is a widely used ventilatory support in children with bronchiolitis in the intensive care setting. No data is available on HFNC use in the general pediatric ward. The aim of this study was to evaluate the feasibility of HFNC oxygen therapy in infants hospitalized in a pediatric ward for moderate-severe bronchiolitis and to assess the changes in ventilatory parameters before and after starting HFNC support. This prospective observational pilot study was carried out during the bronchiolitis season 2011-2012 in a pediatric tertiary care academic center in Italy. Interruptions of HFNC therapy and possible side effects or escalation to other forms of respiratory support were recorded. Oxygen saturation (SpO2), end-tidal carbon dioxide (ETCO2), and respiratory rate (RR), measured for a baseline period of 1 h before and at specific time intervals in 48 h after the start of HFNC were recorded. Twenty-seven infants were included (median age 1.3 months; absolute range 0.3-8.5). No adverse events, no premature HFNC therapy termination, and no escalation to other forms of respiratory support were recorded. Median SpO2 significantly increased by 1-2 points after changing from standard oxygen to HFNC (p <0.001). Median ETCO2 and RR rapidly decreased by 6-8 mmHg and 13-20 breaths per minute, respectively, in the first 3 h of HFNC therapy (p <0.001) and remained steady thereafter.

conclusionsUse of HFNC for oxygen administration is feasible for infants with moderate-severe bronchiolitis in a general pediatric ward. In these children, HFNC therapy improves oxygen saturation levels and seems to be associated with a decrease in both ETCO2 and RR.

Indexed as

Administration, IntranasalAnalysis of VarianceBronchiolitisCarbon DioxideHospitals, PediatricHumansInfantInfant, NewbornMonitoring, PhysiologicOxygenOxygen Inhalation TherapyPilot ProjectsProspective StudiesSeverity of Illness IndexCarbon DioxideOxygen

Identifiers

PMID23900520
PMCPMC7087157
OpenAlexW2022434790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.